Nurse Practitioner in Section, AL Accepting Medicare
5 Nurse Practitioner nurses found. Showing 1 - 5
 Shelby Graves, DNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 60 Main St N, Section, AL 35771 Phone: 256-228-3471 |
Mrs. Alexis Diane Mitchell, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 60 Main St N, Section, AL 35771 Phone: 256-228-3471 |
Jamie Leigh Moore, RN Nurse Practitioner - School Medicare: Not Enrolled in Medicare Practice Location: 6345 County Road 19, Section, AL 35771 Phone: 256-218-1996 |
Brandi Ware, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 60 Main St N, Section, AL 35771 Phone: 256-228-3471 Fax: 256-228-7289 |
Hannah May Luke, NURSE PRACTITIONER Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 302 Main St S, Section, AL 35771 Phone: 256-228-8080 |
News Archive
MorphoSys, Xencor sign worldwide exclusive license, collaboration agreement for XmAb5574 antibody program
MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced today the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development. The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignancies.
Tufts CSDD: Orphan product designations increased up to 425 in 2006-08
The number of orphan product designations in the U.S. more than doubled during the last decade, reflecting growing interest by pharmaceutical and biotech companies in developing products to treat orphan diseases, according to a study recently completed by the Tufts Center for the Study of Drug Development.
The neck played major role in evolution of human brain: Study
By deciphering the genetics in humans and fish, scientists now believe that the neck - that little body part between your head and shoulders - gave humans so much freedom of movement that it played a surprising and major role in the evolution of the human brain, according to New York University and Cornell University neuroscientists in the online journal Nature Communications (July 27, 2010.)
RG7204 Phase III study shows significant survival benefit in patients with metastatic melanoma
Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.
Johns Hopkins researchers reveal how non-CpG methylation may contribute to Rett Syndrome
In normal development, all cells turn off genes they don't need, often by attaching a chemical methyl group to the DNA, a process called methylation. Historically, scientists believed methyl groups could only stick to a particular DNA sequence: a cytosine followed by a guanine, called CpG. But in recent years, they have been found on other sequences, and so-called non-CpG methylation has been found in stem cells, and in neurons in the brain.
› Verified 4 days ago